Remove 2022 Remove Blog Remove FDA Remove Federal Policy
article thumbnail

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule

Healthcare Law Blog

In the alternative, “relevant acceptable evidence” could include case studies, federal policies or reports, internal analyses or investigations. Please refer to our January 5, 2023 , November 4, 2022 and May 16, 2022 blog posts for more information. for Medicare & Medicaid Servs. June 8, 2020). [8] 6, 2023). [10]

article thumbnail

Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs

Drug & Device Law

2022 WL 2276808 (U.S. June 24, 2022), we fully expect attempts by such states to ban FDA-approved prescription drugs that can be used to bring about abortions by chemical means. But when the FDA has approved a product, states no longer have the power to prohibit their sale or use for FDA-approved indications.

FDA 116